Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal
Chemoresistance and hence the consequent treatment failure is considerably challenging in clinical cancer therapeutics. The understanding of the genetic variations in chemoresistance acquisition encouraged the use of gene modulatory approaches to restore anti-cancer drug efficacy. Many smart nanopar...
Saved in:
Main Authors: | Sahar Eljack (Author), Stephanie David (Author), Areeg Faggad (Author), Igor Chourpa (Author), Emilie Allard-Vannier (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment
by: Sahar Eljack, et al.
Published: (2022) -
Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for Efficient Anti-Cancer Activity in HER2+ Breast Cancer Cells
by: Sahar Eljack, et al.
Published: (2022) -
Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer's disease
by: Chinenye Edith Muolokwu, et al.
Published: (2024) -
Internalisation and Biological Activity of Nucleic Acids Delivering Cell-Penetrating Peptide Nanoparticles Is Controlled by the Biomolecular Corona
by: Annely Lorents, et al.
Published: (2021) -
In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model
by: Phuoc Vinh Nguyen, et al.
Published: (2022)